Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

WuXi PharmaTech (Cayman) Inc. (ADR) Company Profile (NYSE:WX)

Consensus Ratings for WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $39.12 (3.77% upside)

Analysts' Ratings History for WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE:WX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/24/2014ZacksUpgradeNeutral -> Outperform$39.60ViewTweet This Rating  Share This Rating on StockTwits
9/23/2014Goldman SachsUpgradeNeutral -> Conviction-BuyViewTweet This Rating  Share This Rating on StockTwits
7/16/2014ZacksUpgradeUnderperform -> Neutral$33.50ViewTweet This Rating  Share This Rating on StockTwits
5/15/2014Morgan StanleyReiterated RatingOverweight$45.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2014OppenheimerBoost Price TargetOverweight$38.00ViewTweet This Rating  Share This Rating on StockTwits
1/7/2014Jefferies GroupBoost Price Target$38.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
11/14/2013OppenheimerBoost Price TargetOutperform$32.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
11/14/2013Janney Montgomery ScottBoost Price TargetNeutral$28.00 -> $31.00ViewTweet This Rating  Share This Rating on StockTwits
11/13/2013Jefferies GroupBoost Price TargetBuy$34.50 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
10/10/2013OppenheimerBoost Price TargetOutperform$28.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
8/15/2013Janney Montgomery ScottInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
8/13/2013Jefferies GroupReiterated RatingBuy$24.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
8/13/2013OppenheimerBoost Price TargetOutperform$25.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
5/14/2013Bank of AmericaReiterated RatingBuy$20.00 -> $23.00ViewTweet This Rating  Share This Rating on StockTwits
5/14/2013OppenheimerReiterated RatingOutperform$22.00 -> $25.00ViewTweet This Rating  Share This Rating on StockTwits
5/14/2013Jefferies GroupReiterated RatingBuy$21.50 -> $24.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2013Credit SuisseReiterated RatingOutperform$18.00 -> $21.60ViewTweet This Rating  Share This Rating on StockTwits
3/11/2013Deutsche BankReiterated RatingBuy$18.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2013Bank of AmericaReiterated RatingBuy$19.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2013JPMorgan Chase & Co.Reiterated RatingOverweight$18.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
3/8/2013Goldman SachsReiterated RatingBuy -> In-Line$18.30ViewTweet This Rating  Share This Rating on StockTwits
3/8/2013Jefferies GroupBoost Price TargetBuy$17.00 -> $21.00ViewTweet This Rating  Share This Rating on StockTwits
11/29/2012BarclaysInitiated CoverageOverweightViewTweet This Rating  Share This Rating on StockTwits
11/13/2012Bank of AmericaLower Price Target$19.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/31/2012 forward)
Discuss WuXi PharmaTech (Cayman) Inc. (ADR)